stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Return on assets
Clover Health Investments, Corp.'s return on assets over the twelve months to 30 September 2026 was 1.90%, up 17.2 percentage points from fiscal 2025 (−15.3%). Over the past ten years it has ranged from −725,298.1% (fiscal 2019) to −7.47% (fiscal 2024); the current reading is higher than 86% of that period. That is below the Healthcare Plans industry median of 3.11% and above the Healthcare sector median of −29.5%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −15.3% | (7.78) |
| FY2024 | −7.47% | 23.47 |
| FY2023 | −30.9% | 7.66 |
| FY2022 | −38.6% | 57.91 |
| FY2021 | −96.5% | 5.52 |
| FY2020 | −102.0% | 725,196.08 |
| FY2019 | −725,298.1% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| PGNY Progyny, Inc. compare | 12.4% |
| OSCR Oscar Health, Inc. compare | 10.9% |
| ELV Elevance Health, Inc. compare | 4.10% |
| CI Cigna Group compare | 3.80% |
| ALHC Alignment Healthcare, Inc. compare | 2.41% |
| HUM Humana Inc. compare | 2.33% |
| CLOV Clover Health Investments, Corp. | 1.90% |
| CNC Centene Corporation compare | 1.81% |
| MOH Molina Healthcare, Inc compare | −0.31% |
| Healthcare Plans industry median | 3.11% |
| Healthcare sector median | −29.5% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement